FDA Accepts Odronextamab BLA Resubmission for R/R Follicular Lymphoma

Media coverage

• Title	FDA Accepts Odronextamab BLA Resubmission for R/R Follicular Lymphoma
  Media name/outlet	Cancernetwork.com
  Country/Territory	United States
  Date	26/02/25
  URL	ct.moreover.com/?a=56119068514&p=1gw&v=1&x=8XCfVB6w8bUlk7NzK96jKQ
  Persons	Tae Min Kim